HOME >> BIOLOGY >> NEWS
First Study To Take Bacteria Directly From Patients' Mouths Further Supports Possible Link Between Gum And Heart Disease

By taking bacteria samples directly from patients' mouths and exposing the samples to human blood platelets, researchers at Temple Univeristy Schools of Dentistry and Medicine have further confirmed a possible link between periodontal bacteria and heart disease.

In recent weeks, a great deal of media attention has been focused on this possible relationship. In fact, since the early 1990s, preliminary studies at other universities have used laboratory strains of mouth bacteria and population data to show this possible link.

Temple's study is the first to take a large number of dental plaque bacteria directly from the mouths of patients with severe periodontal disease and test their effect on blood platelets.

"Almost immediately after we exposed human blood platlets to the dental plaque bacteria, the platelets began to clump together," says Dr. Eugene J. Whitaker, associate professor of Dentistry and lead investigator. "And, out of all the periodontal bacteria we tested, Porphyromanas gingivalis was the only one to cause this clumping, which is a key step in formation of bloodstream thrombi (blockage)."

Porphyromanas gingivalis is the most important bacterial cause of destructive gum diseases in adults. The Temple research findings further support and expand a possible link between periodontal disease and development of athrosclerotic heart disease, a condition resulting from plaque build-up and constriction of coronary heart arteries, and strokes affecting the brain.

"The importance of our findings is that at least 36 million American adults have some form of destructive periodontal disease, which leads to loosening and loss of teeth," says Dr. Thomas E. Rams, a co-investigator and chairman of Temple's Department of Periodontology. "Porphyromanas gingivalis is very frequently in dental plaque causing this disease. These people may be at increased risk
'"/>

Contact: Andrew Smith
asmith01@nimbus.ocis.temple.edu
(215) 707-8229
Temple University Health System
27-Feb-1998


Page: 1 2

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
8. First target for childhood malaria vaccine
9. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
10. First flavors form a lasting impression
11. STN International launches Derwent World Patents Index First View

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... March 24, 2017 Agenus Inc. (NASDAQ: AGEN), ... antibodies and cancer vaccines, today announced participation at the ...  Annual William Blair and Maidstone Life Sciences conference "Cancer ... in New York, NY . Agenus ... 29 at 9:40 am: Robert B. Stein , ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of the world,s ... systems, in terms of costs and resources. However, as the ... of innovative and efficient therapies that demonstrate higher chances of ... cancer treatments, a growing number of patients receiving immuno-oncology therapies ...
Breaking Biology Technology:
Cached News: